1. Dournes G, Grodzki D, Macey J, Girodet PO, Fayon M, Chateil JF, et al. Quiet submillimeter MR imaging of the lung is feasible with a PETRA sequence at 1.5 T. Radiology. 2015; 276:258–226.
2. Kurihara Y, Matsuoka S, Yamashiro T, Fujikawa A, Matsushita S, Yagihashi K, et al. MRI of pulmonary nodules. AJR Am J Roentgenol. 2014; 202:W210–W216.
3. Stolzmann P, Veit-Haibach P, Chuck N, Rossi C, Frauenfelder T, Alkadhi H, et al. Detection rate, location, and size of pulmonary nodules in trimodality PET/CT-MR: comparison of low-dose CT and Dixon-based MR imaging. Invest Radiol. 2013; 48:241–246.
4. Grodzki DM, Jakob PM, Heismann B. Ultrashort echo time imaging using pointwise encoding time reduction with radial acquisition (PETRA). Magn Reson Med. 2012; 67:510–518.
5. Johnson KM, Fain SB, Schiebler ML, Nagle S. Optimized 3D ultrashort echo time pulmonary MRI. Magn Reson Med. 2013; 70:1241–1250.
6. Chandarana H, Heacock L, Rakheja R, DeMello LR, Bonavita J, Block TK, et al. Pulmonary nodules in patients with primary malignancy: comparison of hybrid PET/MR and PET/CT imaging. Radiology. 2013; 268:874–881.
7. Chandarana H, Block TK, Rosenkrantz AB, Lim RP, Kim D, Mossa DJ, et al. Free-breathing radial 3D fat-suppressed T1-weighted gradient echo sequence: a viable alternative for contrast-enhanced liver imaging in patients unable to suspend respiration. Invest Radiol. 2011; 46:648–653.
8. Amin MB, Edge SB, Greene FL, Byrd DR, Brookland RK, Washington MK, et al. AJCC cancer staging manual. 8th ed. New York: Springer International Publishing;2017.
9. Liu Y, Wang H, Li Q, McGettigan MJ, Balagurunathan Y, Garcia AL, et al. Radiologic features of small pulmonary nodules and lung cancer risk in the national lung screening trial: a nested case-control study. Radiology. 2018; 286:298–306.
10. Kuriyama K, Tateishi R, Doi O, Higashiyama M, Kodama K, Inoue E, et al. Prevalence of air bronchograms in small peripheral carcinomas of the lung on thin-section CT: comparison with benign tumors. AJR Am J Roentgenol. 1991; 156:921–924.
11. Kundel HL, Polansky M. Measurement of observer agreement. Radiology. 2003; 228:303–308.
12. Dournes G, Menut F, Macey J, Fayon M, Chateil JF, Salel M, et al. Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution. Eur Radiol. 2016; 26:3811–3820.
13. Bannas P, Bell LC, Johnson KM, Schiebler ML, François CJ, Motosugi U, et al. Pulmonary embolism detection with three-dimensional ultrashort echo time MR imaging: experimental study in canines. Radiology. 2016; 278:413–421.
14. Biederer J, Mirsadraee S, Beer M, Molinari F, Hintze C, Bauman G, et al. MRI of the lung (3/3)-current applications and future perspectives. Insights Imaging. 2012; 3:373–386.
15. Purandare NC, Rangarajan V. Imaging of lung cancer: implications on staging and management. Indian J Radiol Imaging. 2015; 25:109–120.
16. Gai ND, Malayeri A, Agarwal H, Evers R, Bluemke D. Evaluation of optimized breath-hold and free-breathing 3D ultrashort echo time contrast agent-free MRI of the human lung. J Magn Reson Imaging. 2016; 43:1230–1238.
17. Landwehr P, Schulte O, Lackner K. MR imaging of the chest: mediastinum and chest wall. Eur Radiol. 1999; 9:1737–1744.
18. Schwenzer NF, Seith F, Gatidis S, Brendle C, Schmidt H, Pfannenberg CA, et al. Diagnosing lung nodules on oncologic MR/PET imaging: comparison of fast T1-weighted sequences and influence of image acquisition in inspiration and expiration breath-hold. Korean J Radiol. 2016; 17:684–694.
19. Semelka RC, Cem Balci N, Wilber KP, Fisher LL, Brown MA, Gomez-Caminero A, et al. Breath-hold 3D gradient-echo MR imaging of the lung parenchyma: evaluation of reproducibility of image quality in normals and preliminary observations in patients with disease. J Magn Reson Imaging. 2000; 11:195–200.